Author: Max Eisenberg

The case of United States of America ex rel. Adventist Health System of West v. AbbVie Inc., et al., Case No. 24-2180, (9th Cir. 2026) (reversing 2:21-cv-04249-DSF-SK) stands as a watershed moment in the intersection of healthcare regulation and pharmaceutical accountability. On March 17, 2026, the Ninth Circuit Court of Appeals issued a landmark ruling...

In the high-stakes world of healthcare administration, the line between aggressive business management and federal fraud can sometimes become dangerously blurred. A recent and unfolding case in the United States District Court for the Eastern District of Oklahoma, United States of America ex rel. Shannon Dunn and Michael Brandon Morgan v. LTC Accounting Services, LLC,...

For decades, the relationship between the Food and Drug Administration (FDA) and pharmaceutical companies was governed by a simple, if controversial, rule: Doctors can prescribe drugs for any use they want, but the companies that make those drugs can’t say a word about it. This “off-label” silence was the cornerstone of the FDA’s power to...

The integrity of the American healthcare system relies on a fundamental principle: honesty. When private corporations partner with the federal government to provide care for the nation’s most vulnerable populations—seniors and those with disabilities—the trust placed in those entities is immense. However, that trust was recently tested as the U.S. Department of Justice (DOJ) announced...

In the world of healthcare litigation, few cases have rattled the pharmacy benefit manager (PBM) industry as profoundly as United States ex rel. Behnke v. CVS Caremark, No. 2:2014-cv-00824 (E.D. Pa. 2025). What began in 2014 as a whistleblower’s suspicion inside a corporate office culminated in 2025 with a staggering $290 million judgment. This case...

In a significant legal blow to one of the world’s largest engineering and construction firms, a federal jury has reached a $15 million verdict against Fluor Corporation. The verdict, delivered on March 13, 2026, in a Greenville, South Carolina courtroom, concludes a marathon legal battle that spanned nearly 13 years and exposed systemic fraud within...

This latest installment in the world of federal oversight and government accountability takes us to Nevada, where a well-known name in the convenience and gaming industry is facing serious allegations. On March 4, 2026, Judge James C. Mahan of the U.S. District Court for the District of Nevada issued a significant order in the case...

The cleanup of the Hanford Site in Washington state is one of the most complex, expensive, and critical environmental challenges in United States history. Yet, even in a mission of such high stakes, the shadow of corporate fraud can loom large. On March 2, 2026, the U.S. Department of Justice (DOJ) announced that Hanford Mission...

In the complex landscape of healthcare, the integrity of medical decision-making is paramount. Patients must trust that their doctors are recommending treatments based solely on clinical necessity and the best interest of their health, not because of a financial incentive offered to the physician. This foundational trust is what the Anti-Kickback Statute (AKS) is designed...

In the complex ecosystem of American healthcare, the relationship between a hospital and its physicians is the bedrock of patient care. We trust that when a doctor recommends a surgery or a specific facility, that recommendation is based solely on clinical necessity and the best interest of the patient. However, a recent $5.6 million settlement...